Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-02 · accession 0001187443-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-03 | 2026-03-02 | REGN | RYAN ARTHUR F | Dir | S - Sale | $785.50 | -100 | 17.8K | -0.6% | -$78.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 20 | $788.96 | 17,723 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-02 | S | D | 2 | $787.34 | 17,743 | D | — | — | (F12) Represents volume-weighted average price of sales of 2 shares of Company stock on March 2, 2026 at prices ranging from $787.02 to $787.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 3 | Common | Common Stock | 2026-03-02 | S | D | 7 | $786.61 | 17,745 | D | — | — | (F11) Represents volume-weighted average price of sales of 7 shares of Company stock on March 2, 2026 at prices ranging from $786.12 to $786.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 4 | Common | Common Stock | 2026-03-02 | S | D | 11 | $785.48 | 17,752 | D | — | — | (F10) Represents volume-weighted average price of sales of 11 shares of Company stock on March 2, 2026 at prices ranging from $785.02 to $785.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 5 | Common | Common Stock | 2026-03-02 | S | D | 2 | $781.21 | 17,784 | D | — | — | (F6) Represents volume-weighted average price of sales of 2 shares of Company stock on March 2, 2026 at prices ranging from $781.00 to $781.42. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 6 | Common | Common Stock | 2026-03-02 | S | D | 10 | $783.62 | 17,772 | D | — | — | (F8) Represents volume-weighted average price of sales of 10 shares of Company stock on March 2, 2026 at prices ranging from $783.25 to $783.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 7 | Common | Common Stock | 2026-03-02 | S | D | 2 | $782.62 | 17,782 | D | — | — | (F7) Represents volume-weighted average price of sales of 2 shares of Company stock on March 2, 2026 at prices ranging from $782.25 to $782.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 8 | Common | Common Stock | 2026-03-02 | S | D | 7 | $777.46 | 17,796 | D | — | — | (F2) Represents volume-weighted average price of sales of 7 shares of Company stock on March 2, 2026 at prices ranging from $777.08 to $777.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 9 | Common | Common Stock | 2026-03-02 | S | D | 2 | $778.30 | 17,794 | D | — | — | (F3) Represents volume-weighted average price of sales of 2 shares of Company stock on March 2, 2026 at prices ranging from $778.27 to $778.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 10 | Common | Common Stock | 2026-03-02 | S | D | 5 | $779.69 | 17,789 | D | — | — | (F4) Represents volume-weighted average price of sales of 5 shares of Company stock on March 2, 2026 at prices ranging from $779.36 to $779.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 11 | Common | Common Stock | 2026-03-02 | S | D | 3 | $780.69 | 17,786 | D | — | — | (F5) Represents volume-weighted average price of sales of 3 shares of Company stock on March 2, 2026 at prices ranging from $780.13 to $780.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 12 | Common | Common Stock | 2026-03-02 | S | D | 20 | $789.28 | 17,703 | D | — | — | (F13) Represents volume-weighted average price of sales of 20 shares of Company stock on March 2, 2026 at prices ranging from $789.27 to $789.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
| 13 | Common | Common Stock | 2026-03-02 | S | D | 9 | $784.48 | 17,763 | D | — | — | (F9) Represents volume-weighted average price of sales of 9 shares of Company stock on March 2, 2026 at prices ranging from $784.02 to $784.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |